Bone Biologics BBLG
NASDAQ BBLG
$0.34 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST

Bone Biologics (BBLG) Long-Term Debt Repayments (2013 - 2021)

Updated

Bone Biologics' Long-Term Debt Repayments was $10,609 in Q1 2021.

Analysis

Bone Biologics (BBLG) Long-Term Debt Repayments (2013 - 2021) Analysis & Trends

On a trailing twelve-month basis, Bone Biologics' Long-Term Debt Repayments was $633,174 through Mar 31, 2021; for FY2018, it came in at $600,000.

  • Long-Term Debt Repayments shows a four-year compound annual growth rate of -9.5% (FY2014 to FY2018).
  • In earlier years, Long-Term Debt Repayments was $893,371 in FY2014.
  • The Q1 2021 figure marks the highest quarterly Long-Term Debt Repayments since Q4 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Thermo Fisher Scientific 265.71 Bn 242.23 Bn 5.13 Bn 1.11 Bn
2 Abbott Laboratories 189.37 Bn 163.23 Bn 7.39 Bn 1.33 Bn
3 Danaher 164.78 Bn 144.43 Bn 3.84 Bn -
4 Intuitive Surgical 157.85 Bn 138.13 Bn 2.08 Bn -
5 Medtronic 129.66 Bn 94.91 Bn 6.34 Bn -
6 Stryker 121.82 Bn 108.01 Bn 4.25 Bn -
7 Boston Scientific 63.42 Bn 58.86 Bn 3.43 Bn -
8 Edwards Lifesciences 59.49 Bn 42.69 Bn 1.35 Bn -
9 Becton Dickinson 58.38 Bn 55.53 Bn 2.32 Bn 2.00 Bn
10 Bone Biologics 1.34 Mn -18.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 10,609.00
Dec 31, 2014 627,559.00
Jul 31, 2013 -4,994.00
API Access

Bone Biologics Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=BBLG&period=max&api_key=YOUR_API_KEY